Trial Profile
A Phase II/III Double Blind Randomized Trial of BMS-275291 vs. Placebo in Patients Receiving Paclitaxel/Carboplatin Chemotherapy for the Treatment of Advanced or Metastatic Non-Small Cell Lung Cancer.
Status:
Completed
Phase of Trial:
Phase II/III
Latest Information Update: 07 Apr 2020
Price :
$35
*
At a glance
- Drugs Rebimastat (Primary) ; Carboplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Adverse reactions; Therapeutic Use
- 28 Sep 2005 New trial record.